We welcome applications to a 2-year position as a researcher in our Translational Pharmacokinetics and Pharmacodynamics group at the Department of Pharmacy, Uppsala University, Sweden (tPKPD; https://farmaci.uu.se/research/translational-pkpd). The group takes a multidisciplinary approach to improve the understanding of fundamental and functional aspects of PKPD in health and disease, with special focus on drug delivery to the brain.

The position is an important part of the EU IMI2-RIA funded project IM2PACT - Investigating Mechanisms and Models Predictive of Accessibility of Therapeutics Into The Brain (http://im2pact.org). IM2PACT is a consortium of 27 international partners from academia, industry, and small and medium enterprises. The project gives access to a highly international work environment and network.

The researcher will focus on in vivo characterization and validation of novel BBB targets and their potential for brain delivery of biotherapeutics using pharmacokinetic methods. Time will be devoted to experimental research, in particular designing and performing in vivo preclinical studies, bioanalysis of samples using appropriate methods, e.g. ELISA, LC-MS/MS, followed by pharmacokinetic analysis. The duties also include collaboration with IM2PACT consortium partners, writing papers and participating in international meetings. Within the duties of the position may furthermore be supervision of Master students.

The successful candidate should have a PhD in pharmacokinetics, pharmaceutical, biomedical or medical sciences, or related areas. For the full announcement and further qualifications, please go to https://mp.uu.se/web/info/vart-uu/lediga-jobb/-/jobb/357733. The last date for application is November 20, 2020 and starting date is January 4, 2021, or as otherwise agreed.

For further information about the position please contact: Professor Margareta Hammarlund-Udenaes, e-mail mail to: , +4618-471 4300.